Last reviewed · How we verify

NCT04647305: COVPROSHIELD

Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission

Completed NA Last updated 27 April 2021
What this trial tests

NA trial testing Closed face shield with Surgical face mask use in SARS-CoV-2 Infection in 233 participants. Completed in 4 March 2021.

Timeline
16 January 2021
Primary endpoint
4 March 2021
4 March 2021

Quick facts

Lead sponsorUniversity of Los Andes, Columbia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment233
Start date16 January 2021
Primary completion4 March 2021
Estimated completion4 March 2021
Sites1 location across Colombia

Drugs / interventions tested

Conditions studied

Sponsor

University of Los Andes, Columbia

Who can join

18 and older, any sex, with SARS-CoV-2 Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A non-inferiority randomized controlled trial that aims to determine the effectiveness and adherence of the use of closed-face shields and surgical face masks in comparison with the use of surgical face masks for the prevention of SARS-CoV-2 infection in working adults in the city of Bogota, Colombia.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Randomized trials on non-pharmaceutical interventions for COVID-19: a scoping review.
    Hirt J, Janiaud P, Hemkens LG. · · 2022 · cited 24× · PMID 35086864 · DOI 10.1136/bmjebm-2021-111825
  2. Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.
    Pizarro AB, Persad E, Durao S, Nussbaumer-Streit B, et al · · 2022 · cited 17× · PMID 35514111 · DOI 10.1002/14651858.cd015112.pub2
  3. Effectiveness and adherence to closed face shields in the prevention of COVID-19 transmission: a non-inferiority randomized controlled trial in a middle-income setting (COVPROSHIELD).
    Varela AR, Gurruchaga AP, Restrepo SR, Martin JD, et al · · 2022 · cited 5× · PMID 35987694 · DOI 10.1186/s13063-022-06606-0
  4. Randomized trials on non-pharmaceutical interventions for COVID-19 as of August 2021: a meta-epidemiological analysis
    Hirt J, Janiaud P, Hemkens LG. · · 2021 · DOI 10.1101/2021.08.20.21261687

Verify or expand the search:

Other recruiting trials for SARS-CoV-2 Infection

Currently open trials in the same condition.

Other University of Los Andes, Columbia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04647305.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing